Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kanyos Bio, Inc., A Wholly-owned Subsidiary Of Anokion Sa

Clinical trials sponsored by Kanyos Bio, Inc., A Wholly-owned Subsidiary Of Anokion Sa, explained in plain language.

Completed 1 Terminated 1

Early-Stage trial tests drug to tame gluten reaction

Disease control Terminated

This study tested an investigational drug, KAN-101, to see if it could help control the immune system's harmful reaction to gluten in people with celiac disease. Researchers enrolled 128 adults already on a gluten-free diet to test the drug's safety and its effect on a key immune…

Phase: PHASE1, PHASE2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC